Browsing Tag

excipients

In Situ Gelling Nasal Drug Delivery System

Abstract In the nasal cavity, nasal mucosa had a high blood perfusion rate, due to this the absorption of the drug is high as compared to other routes, as well as has increased good bioavailability of drugs at the systemic circulation. To improve the nasal retention time of in-situ gel with nasal…
Read More...

WHO recommends risk management plans for high-risk excipients

The World Health Organization (WHO) has released two draft appendices to a recent draft guideline on good manufacturing practices (GMPs) for excipients. The first document recommends manufacturers develop risk management plans for controlling and preventing contamination of high-risk excipients. A…
Read More...